Literature DB >> 21245438

Process analysis of variables for standardization of antifungal susceptibility testing of nonfermentative yeasts.

Oscar Zaragoza1, Ana C Mesa-Arango, Alicia Gómez-López, Leticia Bernal-Martínez, Juan Luis Rodríguez-Tudela, Manuel Cuenca-Estrella.   

Abstract

Nonfermentative yeasts, such as Cryptococcus spp., have emerged as fungal pathogens during the last few years. However, standard methods to measure their antifungal susceptibility (antifungal susceptibility testing [AST]) are not completely reliable due to the impaired growth of these yeasts in standard media. In this work, we have compared the growth kinetics and the antifungal susceptibilities of representative species of nonfermentative yeasts such as Cryptococcus neoformans, Cryptococcus gattii, Cryptococcus albidus, Rhodotorula spp., Yarrowia lipolytica, Geotrichum spp., and Trichosporon spp. The effect of the growth medium (RPMI medium versus yeast nitrogen base [YNB]), glucose concentration (0.2% versus 2%), nitrogen source (ammonium sulfate), temperature (30°C versus 35°C), shaking, and inoculum size (10(3), 10(4), and 10(5) cells) were analyzed. The growth rate, lag phase, and maximum optical density were obtained from each growth experiment, and after multivariate analysis, YNB-based media demonstrated a significant improvement in the growth of yeasts. Shaking, an inoculum size of 10(5) CFU/ml, and incubation at 30°C also improved the growth kinetics of organisms. Supplementation with ammonium sulfate and with 2% glucose did not have any effect on growth. We also tested the antifungal susceptibilities of all the isolates by the reference methods of the CLSI and EUCAST, the EUCAST method with shaking, YNB under static conditions, and YNB with shaking. MIC values obtained under different conditions showed high percentages of agreement and significant correlation coefficient values between them. MIC value determinations according to CLSI and EUCAST standards were rather complicated, since more than half of isolates tested showed a limited growth index, hampering endpoint determinations. We conclude that AST conditions including YNB as an assay medium, agitation of the plates, reading after 48 h of incubation, an inoculum size of 10(5) CFU/ml, and incubation at 30°C made MIC determinations easier without an overestimation of MIC values.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245438      PMCID: PMC3067191          DOI: 10.1128/AAC.01631-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  In vitro antifungal susceptibilities of Trichosporon species.

Authors:  Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 2.  Echinocandin antifungal drugs.

Authors:  David W Denning
Journal:  Lancet       Date:  2003-10-04       Impact factor: 79.321

3.  Susceptibility patterns and molecular identification of Trichosporon species.

Authors:  Juan L Rodriguez-Tudela; Teresa M Diaz-Guerra; Emilia Mellado; Virginia Cano; Cecilia Tapia; Alexander Perkins; Alicia Gomez-Lopez; Laura Rodero; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans.

Authors:  G St-Germain; C Dion
Journal:  Mycoses       Date:  1996 May-Jun       Impact factor: 4.377

5.  Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia.

Authors:  Eleni Galanis; Linda Hoang; Pamela Kibsey; Muhammad Morshed; Peter Phillips
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

6.  Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology.

Authors:  Linda M N Hoang; John A Maguire; Patrick Doyle; Murray Fyfe; Diane L Roscoe
Journal:  J Med Microbiol       Date:  2004-09       Impact factor: 2.472

7.  Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

8.  Susceptibility testing of Cryptococcus neoformans: a microdilution technique.

Authors:  M A Ghannoum; A S Ibrahim; Y Fu; M C Shafiq; J E Edwards; R S Criddle
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 9.  Pharmacotherapy of yeast infections.

Authors:  Alicia Gómez-López; Oscar Zaragoza; Juan Luis Rodríguez-Tudela; Manuel Cuenca-Estrella
Journal:  Expert Opin Pharmacother       Date:  2008-11       Impact factor: 3.889

Review 10.  New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.

Authors:  Maria Teresa Fera; Erminia La Camera; Angelina De Sarro
Journal:  Expert Rev Anti Infect Ther       Date:  2009-10       Impact factor: 5.091

View more
  13 in total

Review 1.  Factors influencing susceptibility testing of antifungal drugs: a critical review of document M27-A4 from the Clinical and Laboratory Standards Institute (CLSI).

Authors:  Edinaira Sulany Oliveira de Sousa; Ana Claúdia Alves Cortez; Marcia de Souza Carvalho Melhem; Hagen Frickmann; João Vicente Braga de Souza
Journal:  Braz J Microbiol       Date:  2020-08-05       Impact factor: 2.476

2.  Comparison of different in vitro tests to detect Cryptococcus neoformans not susceptible to amphotericin B.

Authors:  Susana Córdoba; Walter Vivot; Wanda Szusz; Guillermina Isla; Graciela Davel
Journal:  Mycopathologia       Date:  2015-02-21       Impact factor: 2.574

Review 3.  Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility.

Authors:  Nina T Grossman; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds.

Authors:  Calliandra Maria de-Souza-Silva; Fernanda Guilhelmelli; Daniel Zamith-Miranda; Marco Antônio de Oliveira; Joshua Daniel Nosanchuk; Ildinete Silva-Pereira; Patrícia Albuquerque
Journal:  J Vis Exp       Date:  2018-02-14       Impact factor: 1.355

5.  Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.

Authors:  Gulsen Hazirolan; Emilia Canton; Selma Sahin; Sevtap Arikan-Akdagli
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

6.  Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species.

Authors:  M S C Melhem; A Bertoletti; H R L Lucca; R B O Silva; F A Meneghin; M W Szeszs
Journal:  Braz J Microbiol       Date:  2014-03-10       Impact factor: 2.476

7.  Mathematical modeling predicts enhanced growth of X-ray irradiated pigmented fungi.

Authors:  Igor Shuryak; Ruth A Bryan; Joshua D Nosanchuk; Ekaterina Dadachova
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

Review 8.  Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen.

Authors:  João N de Almeida Júnior; Christophe Hennequin
Journal:  Front Microbiol       Date:  2016-10-17       Impact factor: 5.640

9.  Phenotypic typing and epidemiological survey of antifungal resistance of Candida species detected in clinical samples of Italian patients in a 17 months' period.

Authors:  Margherita Scapaticci; Andrea Bartolini; Federica Del Chierico; Cristel Accardi; Francesco Di Girolamo; Andrea Masotti; Maurizio Muraca; Lorenza Putignani
Journal:  Germs       Date:  2018-06-04

10.  Post operative fungal endopthalmitis due to Geotrichum candidum.

Authors:  Thein Myint; Matthew J Dykhuizen; Carolyn H McDonald; Julie A Ribes
Journal:  Med Mycol Case Rep       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.